was successfully added to your cart.

Your SEO optimized title page contents
Michael Mayes Illinois Cannabis Consultant

On Wednesday night around 100 industry professionals gathered at the Blackstone Hotel to hear from 2 prominent state employees intimately involved in the roll out of the state’s medical marijuana program. Robert Morgan from the Department of Public Health and Bridget Carlson from the Department of Professional and Financial Regulation gave short statements before answering several questions from those in attendance.

The biggest news announcement of the day was that IL Senate Bill #2636 (SB2636) passed the senate and has made it’s way to the house in Springfield. SB2636 will add myoclonic-astatic epilepsy (Doose Syndrome) to the list of debilitating medical conditions. It also aims to set rules for the issuance of a registry identification card for qualifying patients who are under 18 years of age that are suffering from Doose Syndrome.

Robert briefly covered the progress that has been made since last August and also stressed to those who are frustrated with the speed of the rule making process, to keep in mind that this is only a 4 year pilot program and the expiration date of 12/31/2017 is very real. He reminded everyone that they only have one shot to get this right. They have to be quick, but they also have to be cautious and diligent.

Questions regarding the application process were plentiful. There were also questions raised about political fairness and transparency in a city that has been historically just the opposite. Both Bridget and Robert were quick to explain that their jobs were on the line and that they both are doing their best to keep outside influences away from the decision making process. Bridget also offered some comments about how she expects the application process to be assessed. In her opinion, how applicants present their information, their plan to best serve patients in Illinois, and the individuals that are involved with the group will be the main focus. Solid record keeping and security programs will also be of utmost importance.

Once the rules and regulations are adopted and published, the state estimates they will see tens of thousands of patient applications within the first year. The NCIA will host a two-day national event in Denver, Colorado starting on June 4. Quantum 9’s own Ed Rosenthal, Master Gardener Level III, will be a featured speaker there, along with many other industry experts.

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply